Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (401-410 of 557) with videos related to

Pageof 56
Sort By:
The Lancet. Primary Care|December 26, 2025
Health inequalities and trends in heart failure diagnosis in primary care in England, 2000-21: a national retrospective cohort data-linkage studyClaire A Lawson, Mohammad R Ali, Gerry P McCann, et al.
JACC. Heart Failure|June 15, 2024
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline CharacteristicsMikhail N Kosiborod, David Cherney, Kim Connelly, et al.
Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Nature Medicine|August 31, 2025
Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trialBarry A Borlaug, Jeffrey M Testani, Mark C Petrie, et al.
Cost Effectiveness and Resource Allocation : C/E|November 19, 2015
Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsJulian Nam, Andrew Briggs, Jamie Layland, et al.
JACC. Heart Failure|December 3, 2025
Management of Ischemic Heart Disease in Patients With Heart Failure: JACC: Heart Failure Position StatementLisa M Mielniczuk, Tariq Ahmad, Josip Andelo Borovac, et al.
JACC. Heart Failure|October 31, 2025
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart FailureJames E Udelson, Jan Bělohlávek, Andrej Dukát, et al.
JACC. Heart Failure|September 16, 2025
Frailty and Effects of Semaglutide in Obesity-Related HFpEF: Findings From the STEP-HFpEF ProgramAmbarish Pandey, Dalane W Kitzman, Khaja M Chinnakondepalli, et al.
Heart (British Cardiac Society)|June 18, 2025
Outcome measures for randomised clinical trials and multicentre observational studies of cardiovascular diseases published in major clinical journals: systematic review and evidence mappingAsad Bhatty, Chris Wilkinson, Suleman Aktaa, et al.
Pageof 56

Showing results (401-410 of 557) with videos related to

Sort By:
Pageof 56
The Lancet. Primary Care|December 26, 2025
Health inequalities and trends in heart failure diagnosis in primary care in England, 2000-21: a national retrospective cohort data-linkage studyClaire A Lawson, Mohammad R Ali, Gerry P McCann, et al.
JACC. Heart Failure|June 15, 2024
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline CharacteristicsMikhail N Kosiborod, David Cherney, Kim Connelly, et al.
Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Nature Medicine|August 31, 2025
Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trialBarry A Borlaug, Jeffrey M Testani, Mark C Petrie, et al.
Cost Effectiveness and Resource Allocation : C/E|November 19, 2015
Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsJulian Nam, Andrew Briggs, Jamie Layland, et al.
JACC. Heart Failure|December 3, 2025
Management of Ischemic Heart Disease in Patients With Heart Failure: JACC: Heart Failure Position StatementLisa M Mielniczuk, Tariq Ahmad, Josip Andelo Borovac, et al.
JACC. Heart Failure|October 31, 2025
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart FailureJames E Udelson, Jan Bělohlávek, Andrej Dukát, et al.
JACC. Heart Failure|September 16, 2025
Frailty and Effects of Semaglutide in Obesity-Related HFpEF: Findings From the STEP-HFpEF ProgramAmbarish Pandey, Dalane W Kitzman, Khaja M Chinnakondepalli, et al.
Heart (British Cardiac Society)|June 18, 2025
Outcome measures for randomised clinical trials and multicentre observational studies of cardiovascular diseases published in major clinical journals: systematic review and evidence mappingAsad Bhatty, Chris Wilkinson, Suleman Aktaa, et al.
Pageof 56